Followers | 6 |
Posts | 1163 |
Boards Moderated | 0 |
Alias Born | 10/25/2016 |
Friday, July 07, 2017 11:57:16 PM
Arena Pharmaceuticals stock is one of the best on the Nasdaq today, up 9.7% to trade at $19.73, and just off a new annual high of $19.90, after JMP raised its rating on the stock to "market outperform" from "market perform." The biotech stock is now up 39% year-to-date, and has skyrocketed about 75% since hitting a record low of $11.30 on May 18.
A short squeeze could add fuel to ARNA stock's fire. Short interest represents more than 26% of the equity's total available float, and would take nearly a week to buy back, at Arena Pharmaceuticals' average daily trading volume.
http://www.schaeffersresearch.com/content/news/2017/07/07/amd-stock-rallies-general-electric-hits-another-new-low
$ARNA
For direct communication email me futurebankruptcy at gmail dot com
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM